Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.35 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22610196 | 1.00 | POLB (0.41) | POLBGAACTNNB1KDM4ELMNA | |
| SCHEMBL91435 | 0.88 | POLB (0.33) | POLB | |
| SCHEMBL31661865 | 0.88 | POLB (0.33) | POLB | |
| SCHEMBL31261806 | 0.83 | ATM (0.30) | — | |
| SCHEMBL10339584 | 0.83 | ATM (0.44) | POLBGAARAB9ANPSR1 | |
| SCHEMBL9885421 | 0.81 | TSHR (0.37) | POLBGAA | |
| SCHEMBL23542584 | 0.81 | POLB (0.35) | POLBGAA | |
| SCHEMBL13714112 | 0.80 | POLB (0.41) | POLBGAALMNAMAPTMAPK1 | |
| SCHEMBL112485 | 0.80 | POLB (0.41) | POLBGAALMNAMAPTMAPK1 | |
| SCHEMBL23542587 | 0.79 | TSHR (0.42) | POLBGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3962411-A1 | HIGH REACTIVE INDEX, HIGH ABBE COMPOSITIONS | Johnson & Johnson Surgical Vision, Inc. (US) | 2022-03-09 | — | — | EP | claimed |
| WO-2020225686-A1 | HIGH REACTIVE INDEX, HIGH ABBE COMPOSITIONS | Johnson & Johnson Surgical Vision, Inc. (US) | 2020-11-12 | — | — | WO | claimed |
| JP-57207637-A | — | — | None | — | — | JP | disclosed |
| US-20260028439-A1 | COMPOSITIONS WITH HIGH REFRACTIVE INDEX AND ABBE NUMBER | JOHNSON & JOHNSON SURGICAL VISION INC (US) | 2026-01-29 | — | — | US | disclosed |
| US-12460032-B2 | Compositions with high refractive index and Abbe number | Johnson & Johnson Surgical Vision, Inc. (US) | 2025-11-04 | — | — | US | disclosed |
| US-20240336868-A1 | COMPOSITIONS COMPRISING ADAMANTYL ESTER-CONTAINING COMPOUNDS | THE PROCTER & GAMBLE COMPANY | 2024-10-10 | — | — | US | disclosed |
| US-20240218102-A1 | COMPOSITIONS WITH HIGH REFRACTIVE INDEX AND ABBE NUMBER | Johnson & Johnson Surgical Vision, Inc. | 2024-07-04 | — | — | US | disclosed |
| US-11958923-B2 | Compositions with high refractive index and abbe number | Johnson & Johnson Surgical Vision, Inc. (US) | 2024-04-16 | — | — | US | disclosed |
| US-20240018298-A1 | OLEFINIC COMPOSITIONS COMPRISING HYDROCARBON RESINS | ExxonMobil Product Solutions Company | 2024-01-18 | — | — | US | disclosed |
| US-20240018298-A1 | OLEFINIC COMPOSITIONS COMPRISING HYDROCARBON RESINS | ExxonMobil Product Solutions Company | 2024-01-18 | — | — | US | disclosed |
| US-20230365822-A1 | ELECTRON BEAM CURABLE INK AND IMAGE RECORDING METHOD | FUJIFILM CORPORATION (JP) | 2023-11-16 | — | — | US | disclosed |
| US-20200148908-A1 | CROSSLINKED COATING COMPOSITIONS FOR PACKAGING ARTICLES SUCH AS FOOD AND BEVERAGE CONTAINERS | SWIMC LLC | 2020-05-14 | — | — | US | disclosed |
| WO-2020072776-A1 | POLYMERS FOR SPECIALTY APPLICATIONS | MATERIA, INC. (US) | 2020-04-09 | — | — | WO | disclosed |
| US-7629423-B2 | Alkene-acrylate-norbornene terpolymer and method for preparing the same | LG CHEM, LTD. (KR) | 2009-12-08 | — | — | US | disclosed |
| US-7629423-B2 | Alkene-acrylate-norbornene terpolymer and method for preparing the same | LG CHEM, LTD. (KR) | 2009-12-08 | — | — | US | disclosed |
| US-20090191634-A1 | (METH)ACRYLATE SURFACES FOR CELL CULTURE, METHODS OF MAKING AND USING THE SURFACES | GERON CORPORATION | 2009-07-30 | — | — | US | disclosed |
| US-20090191634-A1 | (METH)ACRYLATE SURFACES FOR CELL CULTURE, METHODS OF MAKING AND USING THE SURFACES | GERON CORPORATION | 2009-07-30 | — | — | US | disclosed |
| US-20070255027-A1 | ALKENE-ACRYLATE-NORBORNENE TERPOLYMER AND METHOD FOR PREPARING THE SAME | LG CHEM, LTD. (KR) | 2007-11-01 | — | — | US | disclosed |
| US-20070255027-A1 | ALKENE-ACRYLATE-NORBORNENE TERPOLYMER AND METHOD FOR PREPARING THE SAME | LG CHEM, LTD. (KR) | 2007-11-01 | — | — | US | disclosed |
| JP-S57207637-A | RESIN COMPOSITION | SEKISUI CHEM CO LTD | 1982-12-20 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260028439-A1 | COMPOSITIONS WITH HIGH REFRACTIVE INDEX AND ABBE NUMBER | SMCHD1, MACF1, LAGE3 | POLB 3786/4885GAA 4856/4885CTNNB1 2914/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.